TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 85 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 85 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 85 | -40.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 143 | -92.7% | 0.00% | – |
| Q1 2022 | $5,000 | -83.9% | 1,959 | -70.4% | 0.00% | – |
| Q4 2021 | $31,000 | +14.8% | 6,625 | +113.6% | 0.00% | – |
| Q3 2021 | $27,000 | -25.0% | 3,102 | +37.7% | 0.00% | – |
| Q2 2021 | $36,000 | -29.4% | 2,253 | -1.3% | 0.00% | – |
| Q1 2021 | $51,000 | +131.8% | 2,283 | +222.9% | 0.00% | – |
| Q4 2020 | $22,000 | +2100.0% | 707 | +2180.6% | 0.00% | – |
| Q3 2020 | $1,000 | – | 31 | +29.2% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 24 | -91.3% | 0.00% | – |
| Q1 2020 | $2,000 | -86.7% | 276 | -74.3% | 0.00% | – |
| Q4 2019 | $15,000 | +1400.0% | 1,074 | +1817.9% | 0.00% | – |
| Q3 2019 | $1,000 | – | 56 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
| MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
| TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
| Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
| K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
| HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
| Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
| Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
| Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
| X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |